The distinctive “O-chassis” which has become the standard across all of Cybot Galactica’s protocol droids, is one of the most recognisable droid designs in galactic history.
An immense and far-ranging entity which devotes an enormous volume of resources advertising its cyborg technology and various droid series, Cybot Galactica remains a major player in the Galactic Trading Exchange.
Involved in all manner of cybernetic enhancements and android technologies, Cybot Galactica engineer much of the galaxy's automated labour, and frequently seek to impose their agenda upon political, industrial and military decision-makers.
As the leading designers of cybernetic equipment and interfaces, Cybot Galactica also finds itself increasingly ostracised among mainstream corporations, thanks largely to the controversial nature of its cybernetics.
The company have overcome a great deal of initially poor publicity surrounding the potentially dangerous nature of their products, and while on the surface many of these offerings have become so mainstream that they no longer provoke suspicion, their cutting-edge developments have brought the company into the spotlight more than once—for all the wrong reasons. Particularly their advances in brain function and enhancement have crossed a previously invisible line; one across which public opinion has not positively moved.
Headquartered on the technologically advanced planet of Lorumaar, their recent research into advances in multi-biological brain function and enhancement are contributing significantly to the field of medicine, in addition to the corporation's own interests in cybernetic biology, though it is yet to be seen whether the public will embrace their recent developments in this area.
Cybot Galactica has invested significant capital into its shared project with AltoVast, which is working under the title Archived Memories. Opponents have suggested this partnership exists only to alleviate the not infrequent suggestion that they have actively attempted to enthral those they have enhanced. Similarly, it has entered into a joint venture with Xenon BioEngineering, tentatively advertised as BioLabour, a further effort to merge android technology with biomechanics, and again with mixed results.
While on the surface many of Cybot Galactica's products have become so mainstream that they no longer provoke outcry, several of their more cutting-edge developments have brought the company into the spotlight recently, increasing the risk of their portfolio substantially.
Recent controversies have also seen the corporation ostracised from particular fields.